CABYR antibody
Principal name
CABYR antibody
Alternative names for CABYR antibody
CBP86, FSP2, Calcium-binding protein 86, Fibrousheathin-2, FSP-2, Fibrousheathin II, Calcium-binding tyrosine phosphorylation-regulated protein, Testis-specific calcium-binding protein CBP86, Cancer/testis antigen 88
Ncbi ID
9606, NP_036321, NP_036321.2, NM_153768, NM_153769, NM_153770, NM_138643, NM_138644, NP_001035883.1, NM_027687, NM_001042419, NM_181731, NM_012189
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of CABYR antibody
- Kit Component:
- - KN302410G1, Cabyr gRNA vector 1 in pCas-Guide vector
- KN302410G2, Cabyr gRNA vector 2 in pCas-Guide vector
- KN302410D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of CABYR expression in transfected 293T cell line (H00026256-T02) by CABYR MaxPab polyclonal antibody.Lane 1: CABYR transfected lysate(41.10 KDa).Lane 2: Non-transfected lysate.
Western blot analysis of CBP86 expression in HepG2 (A); HeLa (B); SP2/0 (C); PC12 (D) whole cell lysates.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP314772 | CABYR (transcript variant 1) |
||||
| Recombinant protein of human calcium binding tyrosine-(Y)-phosphorylation regulated (CABYR), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406955 | CABYR overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY406956 | CABYR overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY406957 | CABYR overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY408542 | CABYR overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY408543 | CABYR overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY430062 | CABYR overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY430295 | CABYR overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY430296 | CABYR overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
